Sign in
CompletedNo phase

Measuring the ACT During Non-cardiac Arterial Procedures.

Key facts

Who runs it
Dijklander Ziekenhuis
Where
Netherlands3 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
1,000 people enrolled
Started
21 Dec 2016
Ended
31 Jan 2024
Type of study
Observational
Treatments tested
  • Measuring the ACT to determine effect of heparin
Record updated
6 February 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • All patients in participating centers undergoing Non-Cardiac Vascular (arterial) Intervention open or endovascular, older than 18 years

Who cannot take part

  • Patients with a known history of coagulation disorders or a EGFR lower than 30 ml/min

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Aim of the MANCO study is to establish for once and for all that monitoring the effect of heparin during NCVI (Non-Cardiac Vascular Interventions) is essential to ensure the individual patient of safe and tailor-made anticoagulation. Not measuring the effect of the administered heparin exposes the patient to unnecessary risks of thrombo-embolic and bleeding complications. First aim of the MANCO study is to prove that the standardized bolus of 5000 IU of heparin, used by 90% of vascular specialists in Europe, results in inadequate anticoagulation in more than 80% of patients. These measurements will be performed using the Hemostasis Management System by Medtronic.

The group in the trial

  • Arterial procedure and ACT measurement

    All patients undergoing an open or endovascular arterial procedure in which heparin is used peri-procedurally and the ACT is measured to determine effect of heparin

    Treatment: Measuring the ACT to determine effect of heparin

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
MANCO: Measuring the ACT During Non-cardiac Arterial Procedures.
Record updated
6 February 2025